Navigation Links
Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)
Date:12/6/2007

CUPERTINO, Calif., Dec. 6 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that the pivotal Phase III trial for Remoxy had successfully met its primary endpoint (p<0.01) that was prospectively defined by the U.S. Food and Drug Administration (FDA) during the Special Protocol Assessment process. Remoxy, an investigational drug based on DURECT's patented ORADUR(TM) technology, is an abuse-deterrent version of long-acting oxycodone, a powerful painkiller available only by prescription. Remoxy is intended to meet the needs of physicians or pharmacists who appropriately prescribe or dispense long-acting oxycodone and who seek to minimize the risks of abuse, misuse or diversion. These successful results were reported today by Pain Therapeutics (Nasdaq: PTIE) and King Pharmaceuticals (NYSE: KG); Pain Therapeutics is DURECT's licensee of the rights to this investigational drug, and they in turn have sublicensed the commercialization rights to King Pharmaceuticals. According to Pain Therapeutics and King Pharmaceuticals, the FDA has agreed in writing that a single Phase III pivotal study is needed to support the regulatory approval of Remoxy. As a result, Pain Therapeutics has stated that they expect to file a New Drug
'/>"/>

SOURCE DURECT Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families
3. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
6. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
7. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
8. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
9. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
10. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
11. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Eli Lilly and ... Sachs 36th Annual Global Healthcare Conference on Tuesday, June ... and president, Elanco Animal Health, will participate in a ... A live audio webcast will be available ... website at http://investor.lilly.com/events.cfm . A replay of the ...
(Date:5/29/2015)... SPARTANBURG, South Carolina , May 29, 2015 /PRNewswire/ ... Health have announced a collaboration designed to provide therapeutic ... the majority of cancer patients living in U.S. communities. ... Molecular Health to harness the power of big data ... of thousands of patients to enable ,accrual on demand, ...
(Date:5/29/2015)... Research and Markets ( ... "Surgical/Operating Microscopes Market by Application & End ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... poised to reach $806.6 million by 2020 from ... 12.3% from 2015 to 2020. , ,Major factors ...
Breaking Medicine Technology:Lilly to Participate in Goldman Sachs Global Healthcare Conference 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... 12 A new software technology is helping to ... by electronically identifying the sperm, eggs, resulting embryos and ... (IVF) treatment cycles. Using non-invasive Radio Frequency Identification (RFID), ... embryos during the course of treatment. If the wrong ...
... ABBOTT PARK, Ill., Nov. 12 Nearly one in three ... and nearly 34 million have low HDL "good" cholesterol levels. ... and trigs, Abbott has launched two Web sites: ... "Unhealthy high triglyceride and low HDL levels are factors that ...
Cached Medicine Technology:New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 3New Web Sites Educate About Triglycerides and HDL Cholesterol 2
(Date:5/30/2015)... May 30, 2015 At 73 years old, ... vibrant health , which she attributes to a lifetime ... of good nutrition with the release of her new book ... Xlibris AU). , “Cook for Health and Longevity” features a ... and mostly organic food . It is designed to ...
(Date:5/30/2015)... 2015 Cyclist Barry Haarde will ... the World 2015: Piles of Miles” near San ... about hemophilia and encourage individuals to support needy ... Save One Life supports nearly 1,200 impoverished children ... through direct sponsorships, scholarships and micro-enterprise grants. Hemophilia ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 San ... that she is offering a free analysis and consultation ... offer coincides with Disability Awareness Month, which was created ... members across the United States such as Polk recognize ... raise awareness about the possibility of disability, as well ...
(Date:5/30/2015)... The iconic American actor, and host ... a new segment on Medical Malpractice. This segment of ... in the health care field. , According to the ... malpractice suits were filed, roughly only 20% of them ... of court, while the remaining 30% were tossed out. ...
(Date:5/30/2015)... May 30, 2015 “ Milli the Snail ... AppWatch, which takes a look at the latest and coolest ... Toohey, the host of AppWatch and technology expert, conducted the ... aesthetic game that engages and educates children. , Interactive mobile ... not all the content and games they are playing are ...
Breaking Medicine News(10 mins):Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... WILMINGTON, Delaware, September 2 According to a ... by MarketsandMarkets,( http://www.marketsandmarkets.com ), the global emerging lighting technologies,market ... recording an,estimated CAGR of 7.9% from 2009 to 2014. ... 39% of the total revenues. , ...
... , , SAN JOSE, Calif., Sept. ... company, today announced that its IsoFlow (TM) infusion ... Drug Administration (FDA) for the direct delivery of medications into highly ... treatment of cancer. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090902/SF69552 ) ...
... What you need to know about vaccinations for swine flu, ... fall, Americans will face a double challenge in getting shots ... and the seasonal variety. , "Two different vaccines are ... Hay, an assistant professor of medicine at the University of ...
... , , , LA JOLLA, ... today announced that Dr. Juliet Singh, President and Chief Executive Officer ... Partners Healthcare Conference in Boston, MA on Wednesday, September 9, 2009 ... can access a live audio webcast via the Internet by visiting ...
... , , WASHINGTON, Sept. 2 Danaher ... has signed a definitive agreement with MDS Inc. (TSX: MDS; ... division of MDS, which includes a 50% ownership position in ... business, and a 100% ownership position in the former Molecular ...
... , , MOUNTAIN VIEW, Calif., Sept. ... it will participate in the following events in September: , , ... Friday, September 11, at 10:20 a.m. ET in Boston, ... 13, in Philadelphia, Late-Breaking oral platform presentation on Saturday, September ...
Cached Medicine News:Health News:MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014 2Health News:MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014 3Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 2Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 3Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 4Health News:Keep Your Flu Shots Straight This Fall 2Health News:Keep Your Flu Shots Straight This Fall 3Health News:Transdel Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 2Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 3Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 4Health News:MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences 2
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... is the #1 Pipettor for sub-microliter ... and reliability. Continuously adjustable. Features lPLUS, ... Easy interchangeable ejector buttons to fit ... rapid pipet tip ejector with three ...
Medicine Products: